Characterization of the DialGuard device for endotoxin removal in hemodialysis |
| |
Authors: | Szathmary Susan Hegyi Edit Amoureux Marie-Claude Rajapakse Nandani Chicorka Lisa Szalai Gyorgy Reszegi Katalin Derbyshire Zachary Paluh Janet Dodson Bryce Grandics Peter |
| |
Institution: | Clarigen, Inc., Carlsbad, CA 92008, USA. |
| |
Abstract: | Bacterial pyrogens, capable of penetrating dialyzer membranes, are responsible for a systemic inflammatory reaction in hemodialysis patients. Dialyzer reuse, involving rinsing of the dialyzer with pyrogen-containing water, may exacerbate this situation. Studies of the mechanism of action of endotoxin suggest that it irreversibly damages the vascular endothelium. The novel endotoxin removal method described here, is based on affinity-binding of endotoxin by the adsorbent ClarEtox, a USP Class VI-certified resin that is the active component of the medical device DialGuard. Under standard hemodialysis operating conditions, challenge of DialGuard with Pseudomonas maltophilia supernatant-spiked dialysate, containing 35-193 EU/ml endotoxin, resulted in endotoxin levels below 0.05 EU/ml in the treated dialysate. DialGuard was able to decrease endotoxin concentrations in the dialysate from a range of 2.39-8.49 to <0.005 EU/ml. DialGuard supports high fluid velocities at low back pressures and can be sanitized using the heat sanitization cycle of hemodialysis machines. DialGuard offers a simple, user-friendly way to reduce the concentration of endotoxin in dialysate and water for dialysis at a low cost. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|